ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Janux Therapeutics
The role supports the execution of complex autoimmune clinical trials from protocol development through study close-out, ensuring compliance with SOPs, ICH/GCP, and regulatory requirements. Responsibilities include study documentation, coordination of equipment and cross‑functional activities, budget assistance, and collaboration with CROs and regulatory affairs.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
